Oxford Clinical Trials Research Unit
We would like to make everyone aware that the OCTRU office continues to be contactable during the current situation regarding COVID-19.
If you have any queries please continue to contact us at email@example.com or for queries about specific trials, please contact the trial teams directly on the numbers on your information sheets or the trial websites.
Welcome to the OCTRU website. The University of Oxford has a long standing tradition in clinical trials and OCTRU based within the University is one of the UKCRC's registered clinical trials units.
20 May 2022
To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.
29 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain
6 April 2022
A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
NIHR CTU SUPPORT
PLEASE NOTE: This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.
Recent OCTRU Publications
Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial.
Costa ML. et al, (2022), Bmj, 376
TRAINING SESSIONS & SEMINARS
Thursday, 09 June 2022, 9.30am to 1.30pm @ Botnar Research Centre G54
Would you like to collaborate with OCTRU?
OCTRU welcomes requests to collaborate, look to see which of our themes your collaboration may fit within.